Learn more about VCU Department of Pathology
VCU Department of Pathology offers Residency and Fellowship Programs, Undergraduate Medical School lectures and laboratories.
VCU Department of Pathology is committed to upholding the tradition of research excellence known at the VCU Medical Center.
VCU Department of Pathology offers a complete range of laboratory testing services in anatomic pathology, clinical pathology, and molecular diagnostics.
Filters:
Combination treatment harnesses cellular recycling system to fight multiple myeloma
Two Pathologists make Richmond Magazine Top Docs list
Eight VCU Pathologists listed as 'Virginia's Top Doctors'
ASCP presents the Israel Davidsohn Award to Dr. Kimberly Sanford
Massey launches art initiative that celebrates cancer patients and researchers
Two VCU researchers named National Academy of Inventors senior members
Four Pathologists make Richmond Magazine 2025 Top Docs list
VCU's Cancer Mouse Models Core marks 10 years
The doctors of the lab: Woon Chow brings us into medicine’s diagnostic nerve center
Massey partners with Hollings to empower the next generation of cancer center leaders
Remembrance of Dr. David Wilkinson
Three VCU Pathologists listed as ‘Virginia’s Top Doctors'
VCU doctor honors mentor with endowed scholarship
New listing of the world’s most-cited scientists includes 11 VCU faculty who rank in the top 50 of their fields
Pathology's new chair Dr. Yang starts December 1st
Massey's BRIDGE postdoctoral fellowship presents for UPRCCCC
Three Pathologists make Richmond Magazine 2024 Top Docs list
Pathology gaining prominence
May/June 2023: Published research at Massey
22 VCU researchers are inducted into National Academy of Inventors
March/April 2023: Published research at Massey
Three Pathologists make Richmond Magazine Top Docs list
January/February 2023: Published research at Massey
Massey scientists pinpoint druggable target in aggressive breast cancer
Dr. Sanford receives ASCP Ward Burdick Award
Massey scientists earn federal grant
Dr. Bos to serve on TMS Committee
With personalized medicine, a shelved cancer drug could get another shot